The Oncologist, Vol. 6, No. 1, 14-23,
February 2001
© 2001 AlphaMed Press
Radiofrequency Ablation of Malignant Liver Tumors
Steven A. Curley
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Correspondence:
Steven A. Curley, M.D., F.A.C.S., Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4095, USA. Telephone: 713-794-4957; Fax: 713-792-0722; e-mail: scurley{at}notes.mdacc.tmc.edu
The majority of patients with primary or metastatic hepatic tumors are not candidates for resection because of tumor size, location near major intrahepatic blood vessels precluding a margin-negative resection, multifocality, or inadequate hepatic function related to coexistent cirrhosis. Radiofrequency ablation (RFA) is an evolving technology being used to treat patients with unresectable primary and metastatic hepatic cancers. RFA produces coagulative necrosis of tumor through local tissue heating. Liver tumors are treated percutaneously, laparoscopically, or during laparotomy using ultrasonography to identify tumors and guide placement of the RFA needle electrode. For tumors smaller than 2.0 cm in diameter, one or two deployments of the monopolar multiple array needle electrode are sufficient to produce complete coagulative necrosis of the tumor. However, with increasing size of the tumor, there is a concomitant increase in the number of deployments of the needle electrode and the overall time necessary to produce complete coagulative necrosis of the tumor. In general, RFA is a safe, well-tolerated, effective treatment for unresectable hepatic malignancies less than 6.0 cm in diameter. Effective treatment of larger tumors awaits the development of more powerful, larger array monopolar and bipolar RFA technologies.
Key Words. Radiofrequency ablation • Liver • Hepatocellular cancer • Liver metastases
Related articles in The Oncologist:
- Emerging New Opportunities for Patients with Hepatic Metastases from Colorectal Cancer or Primary Hepatocellular Cancer
- H.M. Pinedo and C.J. van Groeningen
The Oncologist 2001 6: 12-13.
[Full Text]
- Radiofrequency Ablation of Unresectable Hepatic Malignancies: Lessons Learned
- Anton J. Bilchik, Thomas F. Wood, and David P. Allegra
The Oncologist 2001 6: 24-33.
[Abstract]
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
H. Higgins and D. L. Berger
RFA for Liver Tumors: Does It Really Work?
Oncologist,
July 1, 2006;
11(7):
801 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Sutherland, J. A. R. Williams, R. T. A. Padbury, D. C. Gotley, B. Stokes, and G. J. Maddern
Radiofrequency ablation of liver tumors: a systematic review.
Arch Surg,
February 1, 2006;
141(2):
181 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Steinke, J. King, D. W. Glenn, and D. L. Morris
Percutaneous Radiofrequency Ablation of Lung Tumors with Expandable Needle Electrodes: Tips from Preliminary Experience
Am. J. Roentgenol.,
September 1, 2004;
183(3):
605 - 611.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Fornage, N. Sneige, M. I. Ross, A. N. Mirza, H. M. Kuerer, B. S. Edeiken, F. C. Ames, L. A. Newman, G. V. Babiera, and S. E. Singletary
Small ( [Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Steinke, D Glenn, J King, and D L Morris
Percutaneous pulmonary radiofrequency ablation: difficulty achieving complete ablations in big lung lesions
Br. J. Radiol.,
October 1, 2003;
76(910):
742 - 745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D'Ippolito, M. Ahmed, G. D. Girnun, K. E. Stuart, J. B. Kruskal, E. F. Halpern, and S. N. Goldberg
Percutaneous Tumor Ablation: Reduced Tumor Growth with Combined Radio-frequency Ablation and Liposomal Doxorubicin in a Rat Breast Tumor Model
Radiology,
July 1, 2003;
228(1):
112 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O Schaefer, C Lohrmann, and M Langer
CT-guided radiofrequency ablation of a bronchogenic carcinoma
Br. J. Radiol.,
April 1, 2003;
76(904):
268 - 270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Lin, C.-J. Lin, H.-J. Chung, C.-W. Hsu, and C.-Y. Peng
Power Rolloff During Interactive Radiofrequency Ablation Can Enhance Necrosis When Treating Hepatocellular Carcinoma
Am. J. Roentgenol.,
January 1, 2003;
180(1):
151 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.M. Pinedo and C.J. van Groeningen
Emerging New Opportunities for Patients with Hepatic Metastases from Colorectal Cancer or Primary Hepatocellular Cancer
Oncologist,
February 1, 2001;
6(1):
12 - 13.
[Full Text]
|
 |
|
Copyright © 2001 by AlphaMed Press.
|
|